{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:46:41Z","timestamp":1778251601852,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1999,8,1]],"date-time":"1999-08-01T00:00:00Z","timestamp":933465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":5099,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Cell"],"published-print":{"date-parts":[[1999,8]]},"DOI":"10.1016\/s1097-2765(00)80367-6","type":"journal-article","created":{"date-parts":[[2004,5,4]],"date-time":"2004-05-04T12:29:33Z","timestamp":1083673773000},"page":"199-207","source":"Crossref","is-referenced-by-count":709,"title":["Reversible Tumorigenesis by MYC in Hematopoietic Lineages"],"prefix":"10.1016","volume":"4","author":[{"given":"Dean W.","family":"Felsher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.Michael","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S1097-2765(00)80367-6_BIB1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","article-title":"The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice","volume":"318","author":"Adams","year":"1985","journal-title":"Nature"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB2","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1126\/science.2144057","article-title":"Suppression of human colorectal carcinoma cell growth by wild-type p53","volume":"249","author":"Baker","year":"1990","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1128\/MCB.18.1.85","article-title":"A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis","volume":"18","author":"Barrington","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(91)90636-D","article-title":"Molecular themes in oncogenesis","volume":"64","author":"Bishop","year":"1991","journal-title":"Cell"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB5","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1002\/j.1460-2075.1994.tb06488.x","article-title":"Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene","volume":"13","author":"Bodrug","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB6","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.2300823","article-title":"Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene","volume":"247","author":"Bookstein","year":"1990","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0962-8924(98)01251-3","article-title":"Control of cell proliferation by Myc","volume":"8","author":"Bouchard","year":"1998","journal-title":"Trends Cell Biol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB8","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.4049\/jimmunol.156.9.3141","article-title":"A role for c-myc in the regulation of thymocyte differentiation and possibly positive selection","volume":"156","author":"Broussard-Diehl","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB9","first-page":"193","article-title":"c-myc and functionally related oncogenes induce both high rates of sister chromatid exchange and abnormal karyotypes in rat fibroblasts","volume":"132","author":"Cerni","year":"1986","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1128\/MCB.18.1.536","article-title":"MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification","volume":"18","author":"Chernova","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MCB.19.1.1","article-title":"c-myc target genes involved in cell growth, apoptosis, and metabolism","volume":"19","author":"Dang","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB12","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1182\/blood.V90.9.3691","article-title":"The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL-positive cells","volume":"90","author":"Deininger","year":"1997","journal-title":"Blood"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB13","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1073\/pnas.92.8.3576","article-title":"Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene","volume":"92","author":"Efrat","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB14","doi-asserted-by":"crossref","first-page":"3610","DOI":"10.1128\/MCB.5.12.3610","article-title":"Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product","volume":"5","author":"Evan","year":"1985","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB15","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0955-0674(95)80066-2","article-title":"Apoptosis and the cell cycle","volume":"7","author":"Evan","year":"1995","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB16","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1126\/science.273.5280.1384","article-title":"Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen","volume":"273","author":"Ewald","year":"1996","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1096\/fasebj.12.9.633","article-title":"The molecular role of Myc in growth and transformation","volume":"12","author":"Facchini","year":"1998","journal-title":"FASEB J."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB18","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1073\/pnas.96.7.3940","article-title":"Transient excess of MYC activity can elicit genomic instability and tumorigenesis","volume":"96","author":"Felsher","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB19","doi-asserted-by":"crossref","first-page":"9302","DOI":"10.1073\/pnas.91.20.9302","article-title":"Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter","volume":"91","author":"Furth","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB20","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","article-title":"Tight control of gene expression in mammalian cells by tetracycline-responsive promoters","volume":"89","author":"Gossen","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB21","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1126\/science.7792603","article-title":"Transcriptional activation by tetracyclines in mammalian cells","volume":"268","author":"Gossen","year":"1995","journal-title":"Science"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1084\/jem.167.2.353","article-title":"The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells","volume":"167","author":"Harris","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB23","series-title":"Manipulating the mouse embryo","author":"Hogan","year":"1986"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB24","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0092-8674(91)90637-E","article-title":"Cooperation between oncogenes","volume":"64","author":"Hunter","year":"1991","journal-title":"Cell"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB25","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1073\/pnas.93.20.10933","article-title":"Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice","volume":"93","author":"Kistner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB26","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nm0895-792","article-title":"Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice","volume":"1","author":"Kohl","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002770050404","article-title":"Antisense strategies for the treatment of hematological malignancies and solid tumors","volume":"77","author":"Kronenwett","year":"1998","journal-title":"Ann. Hematol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB28","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/sj.onc.1202175","article-title":"Non-Ras targets of farnesyltransferase inhibitors","volume":"17","author":"Lebowitz","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB29","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0092-8674(86)90280-1","article-title":"Consequences of widespread deregulation of the c-myc gene in transgenic mice","volume":"45","author":"Leder","year":"1986","journal-title":"Cell"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","article-title":"Genetic instabilities in human cancers","volume":"396","author":"Lengauer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB31","first-page":"277","article-title":"c-Myc over-expression associated DHFR gene amplification in hamster, rat, mouse and human cell lines","volume":"12","author":"Mai","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB32","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1146\/annurev.bi.61.070192.004113","article-title":"myc function and regulation","volume":"61","author":"Marcu","year":"1992","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB33","first-page":"21","article-title":"Use of transgenic mice to study myc family gene function in normal mammalian development and in cancer","volume":"5","author":"Morgenbesser","year":"1994","journal-title":"Sem. Cancer Biol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB34","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1073\/pnas.93.13.6665","article-title":"Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells","volume":"93","author":"Plattner","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB35","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/jnci\/90.15.1146","article-title":"Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model","volume":"90","author":"Smith","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB36","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.1073\/pnas.95.21.12580","article-title":"Doxycycline control of prion protein transgene expression modulates prion disease in mice","volume":"95","author":"Tremblay","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB37","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1200\/JCO.1996.14.9.2473","article-title":"Single-photon emission computed tomography gallium imaging versus computed tomography","volume":"14","author":"Vose","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/S1097-2765(00)80367-6_BIB38","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(96)11103-X","article-title":"BCL-2 antisense therapy in patients with non-Hodgkin lymphoma","volume":"349","author":"Webb","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S1097-2765(00)80367-6_BIB39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.170.3.711","article-title":"Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice","volume":"170","author":"Yukawa","year":"1989","journal-title":"J. Exp. Med."}],"container-title":["Molecular Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276500803676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097276500803676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,13]],"date-time":"2024-01-13T09:15:07Z","timestamp":1705137307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097276500803676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1999,8]]}},"alternative-id":["S1097276500803676"],"URL":"https:\/\/doi.org\/10.1016\/s1097-2765(00)80367-6","relation":{},"ISSN":["1097-2765"],"issn-type":[{"value":"1097-2765","type":"print"}],"subject":[],"published":{"date-parts":[[1999,8]]}}}